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Renal activation of extracellular signal-regulated kinase in rats In autosomal-dominant polycystic kidney disease
with autosomal-dominant polycystic kidney disease. (ADPKD), cysts arise in renal tubules due to loss of
Background. Abnormal proliferation of renal tubule epithe- function mutations in proteins involved in epithelial de-lial cells is a central factor in the biogenesis and sustained ex-
velopment and repair [1–4]. Evidence indicates that germpansion of cysts in autosomal-dominant polycystic kidney dis-
ease (ADPKD). Recent evidence from in vitro studies of human cell mutations are insufficient to cause cysts to form in
cyst wall epithelial cells has implicated a role for the mitogen- renal tubules; rather a second (somatic) “hit” in the other-
activated protein (MAP) kinase pathway in this aberrant prolif-
wise normal allele is required to initiate cyst formationeration. To determine the extent to which this signaling path-
[2, 5–7]. In human ADPKD, each cyst that develops inway is involved in cyst pathogenesis in vivo, we measured the
expression of select components of the MAP kinase cascade in widely scattered tubules appears to derive from a single
Han:SPRD rats with ADPKD at an early stage of the disease. aberrantly proliferative daughter cell.
Methods. Kidneys of 8-week-old normal Han:SPRD rats
The pathogenetic steps in cyst biogenesis beyond the(/) or rats heterozygous (Cy/) for ADPKD were examined
“second hit” can be examined most clearly in spontane-by Western blot analysis and immunohistochemistry to deter-
mine the expression of extracellular-regulated kinase (ERK), ous animal models of renal cystic disease. In one of these,
phosphorylated ERK (P-ERK), Raf-1 (MAPKKK), phosphor- the Han:SPRD Cy rat, a mutation has been mapped to
ylated Raf-1 (P-Raf-1), B-Raf, Rap-1 and phosphorylated pro-
rat chromosome 5 [8]. The renal tubules in these animalstein kinase A (P-PKA).
appear to develop normally in heterozygous (Cy/) ani-Results. P-ERK was expressed to a greater extent in Cy/
kidneys (3.74  1.07 fold) than in normal kidneys, whereas mals until about 2 to 3 weeks of age, whereupon scattered
ERK abundance was not different. P-Raf-1 levels were higher pars recta segments of proximal tubules exhibit focal
in Cy/ than in / kidneys (1.53  0.08 fold) consistent with
areas with intense epithelial cellular proliferation, mor-upstream stimulation of receptor tyrosine kinase. B-Raf and
phologic de-differentiation and tubule basement mem-Raf-1 abundances were greater in Cy/ than in / (1.74 
0.25 and 1.27 0.08 fold, respectively). In Cy/, immunohisto- brane thickening [9–11]. Genetic evidence of a somatic or
chemistry showed increased P-ERK and B-Raf expression in “second hit” type of mutation has not been confirmedthe abnormal mural epithelial cells within cysts. These findings,
in the rat, although such a mechanism seems likely intogether with the detection of P-PKA and the small G protein,
view of the focal nature of cyst formation and the ex-Rap-1, in cyst epithelial cells, implicate a potential role for
cyclic adenosine monophosphate (AMP) in the activation of traordinarily rapid progression of the disease in homozy-
ERK in ADPKD cells. gous (Cy/Cy) animals in which both alleles are abnormal.Conclusions. We conclude that the MAP kinase pathway is
In the Han:SPRD rat it appears that the focal patchesactivated to the level of ERK in the abnormal mural epithelial
cells lining cysts in animals with a dominantly inherited type of of proliferating tubule epithelial cells eventually extend
polycystic kidney disease. We suggest that cAMP, acting through the tubule wall to form a saccular cyst. The cystic portions
PKA, Rap-1 and B-Raf, may contribute to the activation of ERK of the tubule of origin are associated in most cases within a way that complements receptor tyrosine kinase-mediated
dramatic thickening of the underlying tubule basementagonists in the promotion of cyst enlargement.
membrane and subjacent interstitial compartment, to-
gether with the influx of macrophages and nonspecificKey words: cyclic AMP, adenylyl cyclase, B-Raf, MAPK, tyrosine ki-
nase, ERK, cell proliferation. interstitial cells [12]. Focal epithelial proliferation, re-
modeling of tubule basement membranes, increased apo-Received for publication March 21, 2002
ptosis and interstitial inflammation and fibrosis, forcesand in revised form July 16, 2002
Accepted for publication September 12, 2002 at work in all polycystic disorders, conjointly lead to the
loss of renal function [13, 14]. 2003 by the International Society of Nephrology
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Recent evidence indicates that in human ADPKD, described [27]. Heterozygotes were bred in order to in-
germ-line mutations of either PKD1 or PKD2 genes to- crease the yield of Cy/ in each litter. Offspring were
gether with a somatic mutation in the normal allele, cause weaned at 3 weeks of age and homozygous cystic animals
impaired regulation of non-specific, Ca-permeable (Cy/Cy) were sacrificed. A noncystic strain of normal
cation channels displayed in the increased proliferation (/) Sprague-Dawley animals served as controls for
of relatively undifferentiated tubule epithelial cells [15]. the Cy/Cy and Cy/. In most experiments, animals were
Cells cultured from the walls of human ADPKD cysts sacrificed at 8 weeks of age. Animals were anesthetized
proliferate at an accelerated rate in response to cyclic with isoflurane (Baxter Healthcare Corp., Deerfield, IL,
adenosine monophosphate (cAMP) [16, 17]. On the USA) and both kidneys removed rapidly causing fatal
other hand, this nucleotide ordinarily inhibits the growth exsanguination. Both kidneys were quickly weighed. The
of cells derived from normal human kidneys [18, 19], left kidney was homogenized in lysis buffer to extract
suggesting that fundamental programs in the terminal proteins and the right kidney was sectioned and im-
differentiation and regulation of growth in renal tubule mersed in 4% paraformaldehyde. The genotype was de-
cells are radically altered by mutations in the polycystins. termined by gross inspection of the kidney sections.
Although the cause of ADPKD rests in mutated genes, Whole kidneys in lysis buffer were homogenized by
the rate at which kidneys enlarge and renal function de- Polytron for 20 seconds in 1 mL/g kidney weight of
clines can be modified by extra-genetic factors. In the ice-cold lysis buffer (TLB; 20 mmol/L Tris [pH 7.4],
Han:SPRD Cy rat, for example, acidosis, potassium de- 137 mmol/L NaCl, 25 mmol/L beta-glycerophosphate,
pletion and oral protein loading, which individually in- 2 mmol/L ethylene diamine tetra-acetic acid [EDTA],
crease renal tubule cell hypertrophy in normal animals, 1 mmol/L sodium orthovanadate, 2 mmol/L dithiothrei-
greatly accelerated the enlargement of cysts and progres- tol, 1 mmol/L phenylmethlsulfonyl fluoride, 5g/mL apro-
sion of renal dysfunction [20] . Conversely, the adminis- tinin, and 5 g/mL leupeptin with 1% Triton X-100). In-
tration of alkali diminished the rate of cyst growth and soluble material was removed by centrifugation (3000 g,
protected renal function in the Han:SPRD model of 40 minutes.). The protein content of each kidney lysate
ADPKD [21] and the administration of an antiprolifera- was measured using a BCA Protein Assay Kit (Pierce,
tive 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) Rockford, IL, USA). Samples were stored at 80C.
reductase inhibitor or an anti-inflammatory corticoste-
roid slowed cyst expansion and reduced the rate of func- Western blot
tional decline [22]. These findings have reinforced the Lysates (protein, 20 g/lane, except for 60 g/lane for
view that in human PKD the rate of renal cyst growth detecting the P-PKA regulatory subunit) were resolved
is decided by more than the mutations in polycystin. In by sodium dodecyl sulfate-polyacrylamide gel electropho-
this view, mutated polycystins are thought to establish resis (SDS-PAGE, 10% in a mini-protean 3 cell electro-
an altered cellular phenotype within renal tubules in phoresis module assembly, Bio-Rad Laboratories, Hercu-
which ordinary regulatory hormones, growth factors, cy- les, CA, USA) and transferred to nitrocellulose membrane
tokines, and chemokines have prominent roles in the (Optitran; Midwest Scientific, Valley Park, MO, USA) at
promotion of disease progression.
4C. After transfer, the membranes were blocked with
Recent studies have led to the view that the adenylyl
2% or 5% milk in TBS-T (20 mmol/L Tris-HCl, pH 8.0,
cyclase and receptor tyrosine kinase (RTK) pathways
137 mmol/L NaCl, and 0.05% Tween 20). Blocking was
may be mediators of cyst growth and disease progression
carried out for 1 hour at room temperature or overnight
in polycystic kidney disorders [16, 17, 23–25]. In the cur-
at 4C. Blocked membranes were incubated in primaryrent study, we used immunoblotting and immunohisto-
antibody diluted 1:2000 to 5000 in 5% milk-TBS-T forchemistry to explore key components of these pathways
2 hours at room temperature or overnight at 4C. Mem-in cystic kidneys of the Han:SPRD Cy rat, a well-charac-
branes were then washed three times with TBS-T andterized model of ADPKD [26]. The results support the
incubated with secondary antibody conjugated to horse-view that the cAMP and RTK pathways have convergent
radish peroxidase (HRP) diluted 1:2000 to 5000 in 2%and complementary roles in promoting disease progres-
or 5% milk in TBS-T for 1 hour. The membranes weresion in this model of ADPKD.
washed three times with TBS-T and proteins visualized
on x-ray film using an enhanced chemiluminescence sys-
METHODS tem (ECL; Amersham Life Sciences, Arlington Heights,
IL, USA). Blots were scanned using Scion-modified NIHHan:SPRD Cy rats of the Sprague-Dawley strain were
image software for PC (Scion Corporation, Frederick,obtained from the original colony in Hanover, Germany
MD, USA; www.scioncorp.com) and images were quan-[26] . They were maintained with free access to water and
tified in arbitrary intensity units. Male/ kidneys werefood (Purina Rodent Chow, Bethlehem, PA, USA) at
the University of Kansas Medical Center as previously used as the point of reference (1.00). Absolute intensity
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values of Cy/ and Cy/Cy kidneys were compared to RESULTS
/ males and expressed as fold changes. Rats of the Han:SPRD strain carrying a mutation in
only one of the Cy genes developed within 3 weeks after
Immunohistochemistry birth renal cysts that were barely perceptible by gross
Right kidneys were embedded in paraffin and immu- inspection of cut sections (Fig. 1). By contrast, the kid-
nohistochemistry performed on 4m thick sections. Sec- neys of Cy/Cy animals were greatly enlarged and dif-
tions were deparaffinized and rehydrated. To unmask fusely cystic. By 8 weeks, the cystic disease of Cy/ ani-
antigens, slides were heated to 100C for 15 minutes in mals had progressed significantly and differences in renal
10 mmol/L sodium citrate buffer (pH 6.0). Endogenous disease severity between males and females was clear.
Previous studies have established that renal function isperoxidase activity was quenched by incubating sections
normal at 8 weeks of age in female and slightly decreasedin 0.3% H2O2/methanol for 30 minutes. Sections were
in male Cy/ rats.incubated with primary antibody at a concentration of
The levels of P-ERK and ERK were determined by1:100 to 10,000 overnight at 4C. After incubation with
Western blot in the kidneys of 8-week-old/ and Cy/biotinylated antirabbit secondary antibody at a concen-
male rats. The p42 and p44 isoforms of P-ERK weretration of 1:50 to 500, peroxidase-conjugated streptavidin
present in Cy/ to a greater extent than in / kidneys(Histofine: Nichirei Biosciences, Tokyo, Japan) immu-
(Fig. 2A). A third P-ERK band with a molecular weightnoreaction products were developed using 3,3-diamino-
greater than p-p44 was faintly visible in / kidneysbenzidine (DAB) as the chromogen, with standardized
and strikingly more intense in Cy/ kidneys. Althoughdevelopment times. Sections were then counterstained
the intensity of the higher weight band changed in con-with Omni hematoxylin.
cert with the p42 and p44 isoforms, we quantified only
the p42 and p44 bands. P-ERK was 3.74  1.07 foldAntibodies
greater in eight Cy/ than in seven / male kidneysWestern blots. Primary antibodies from Santa Cruz
(P  0.02), whereas total ERK abundance in the sameBiotechnolgy (Santa Cruz, CA, USA) included ERK-1
kidneys was not different between/ and Cy/ (1.03(K-23, sc-94), P-ERK (E-4, sc-7383), B-Raf (C-19, sc-166),
0.03 fold, P 	 0.23).Raf-1 (C-12, sc-133), Rap-1 (sc-12905), PKA C
 (C-20,
P-Raf-1 levels were also increased 1.53  0.09 foldsc-903), PKA RII
 (M-20, sc-909), P-PKA C
 (Ser 96,
(N 6, P 0.001) in Cy/ in comparison to/ kidneyssc-903), and P-PKA RII
 (Ser96) from Upstate Biotech-
(Fig. 2C) and the abundances of Raf-1 (74 kD) and B-Rafnology (Waltham, MA, USA). These primary antibodies
(98 kD) were increased in Cy/ to a greater extent thanwere also used for immunohistochemistry with the ex-
in / kidneys, 1.27  0.08 fold (N  11, P  0.001)ceptions that P-ERK (Sigma M8159, Sigma Chemical
and 1.74  0.25 fold (N  8, P  0.011), respectively
Co., St. Louis, MO, USA) and Raf-1 (Santa Cruz E-10,
(Fig. 2B). Pre-incubation with immunizing peptides strik-
sc-7267) were substituted for this purpose. Secondary
ingly reduced or eliminated the P-ERK and B-Raf reac-
antibodies conjugated to HRP were goat antirabbit im- tive bands in Western blots of both / and Cy/ kid-
munoglobulin (IgG) (sc-2054), rabbit antimouse IgG neys (data not shown).
(sc-2055), donkey antigoat IgG (sc-2056) from Santa Select components of the MAP kinase signaling path-
Cruz Biotechnologies, Santa Cruz, CA, USA, and goat way were localized within the kidneys by immunohisto-
antirabbit IgG (PI-1000) from Vector Laboratories, Bur- chemistry. In / kidneys there was weak, diffuse ex-
lingame, CA, USA. Secondary antibodies conjugated to pression of ERK, with the exception of distal tubules
biotin for immunohistochemistry were goat antirabbit where the level was relatively intense (Fig. 3A). ERK
IgG (111-065-003), goat antimouse IgG (115-065-003) was detected at relatively low levels in all mural cells
and rabbit antimouse IgG (305-065-003) from Jackson Im- within cysts (Fig. 3 E, H) and in the adjacent normal
munoResearch, West Grove, PA, USA. Blocking peptide tubules (Fig. 3E). In the same / kidneys, P-ERK was
experiments utilized P-ERK (Santa Cruz sc-7383P) and not expressed above background in the distal tubules or
B-Raf (Santa Cruz sc-166P). In these, the primary anti- elsewhere (Fig. 3B). By contrast, P-ERK was focally
bodies were mixed with a fivefold (by weight) excess of expressed at relatively high levels in patches of epithe-
blocking peptide in phosphate-buffered saline (PBS) and lium within cortical cysts of Cy/ animals (Fig. 3 C, D,
incubated overnight at 4C. This reagent was then added and G). Figure 3D shows two adjacent cysts that are es-
to tissue sections to give an amount of antibody-antigen pecially informative in this respect. Each cyst appeared
complex equal to that in the experimental section. to contain two different types of epithelia. Cells of one
Mean and SEM were calculated in the usual way. type of cyst epithelium appeared relatively normal and
Levels of significance (P 	 0.05) were determined by un- stained intensely pink with hematoxylin and eosin (Fig. 3I),
as did adjacent normal proximal tubules (Fig. 3 F and I).paired t test.
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Fig. 1. Progression of polycystic disease in the Han:SPRD rat. Mid-coronal hemisections stained with hematoxylin and eosin. Cystic changes were
detected in the cortex of 3-week-old male Cy/ animals. Cy/Cy kidneys of either sex were greatly enlarged and cystic at 3 weeks of age. The
Cy/Cy animals were sacrificed at 3 weeks of age. In 8-week-old animals, cystic progression was greater in male than in female Cy/. At 8 weeks,
the serum urea nitrogen levels were slightly elevated in males and normal in females [27].
These apparently normal cells did not express P-ERK. was the expression of P- ERK in the overlying abnormal
cystic cells (Fig. 3 C to I).Closer examination of one of the cysts showed that the
light pink cells (Fig. 3I) were flattened, lacked brush P-ERK was also evaluated in 8-week-old female rats
that generally had a milder degree of cystic disease (Fig. 1).borders and expressed P-ERK (Fig. 3G). The “chimeric”
tubule cysts in Figure 3 appear to be transitional struc- P-ERK expression was not as robust in the females as
in male Cy/ kidneys (Fig. 4), but was greater than intures in which cells that have been transformed by muta-
tions in the Cy protein are replacing the normal tubule / kidneys (data not shown). P-ERK was also evalu-
ated in male and female Cy/Cy rats. In the controlepithelium.
It is also important to note that the underlying base- 3-week-old animals, P-ERK was increased above the
levels seen in adult normal (/) animals (data notment membranes and subjacent interstitium beneath the
abnormal cells were distinctly abnormal (Fig. 3 C to I). shown), probably owing to the fact that the kidneys were
still growing at this immature stage of development. InThe basement membranes were thickened and the inter-
stitium was widened and infiltrated with mononuclear the greatly enlarged Cy/Cy kidneys at 3 weeks of age
(Fig. 1), P-ERK was expressed in western blots and bycells. The transition between normal cells, tubule base-
ment membrane, and interstitium and abnormal cells immunohistochemistry at levels exceeding that of male
Cy/ animals (Fig. 4).and thickened tubule basement membrane was abrupt as
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Fig. 2. Expression of extracellular-related ki-
nase (ERK) pathway proteins. Kidneys of two
normal male (/) and two cystic male
(Cy/) animals from the same litter at 8 weeks
of age. Western blots of phosphorylated ERK
(P-ERK), B-Raf, phosphorylated (P-Raf-1)
and Raf-1 are shown with respective molecu-
lar weights of these components. (A) P-ERK
was expressed to a greater extent in Cy/ than
in / kidneys. A third band of P-ERK of
higher molecular weight than p44 was consis-
tently seen in male Cy/ and male and female
Cy/Cy kidneys (data not shown), and to a
much lesser extent in / animals of either
sex. ERK expression was not appreciably dif-
ferent between / and Cy/ animals. (B)
B-Raf abundance was increased in Cy/ in
comparison to / animals. (C ) P-Raf-1 and
Raf-1 levels were increased in Cy/ in com-
parison to / animals.
In Cy/ animals, B-Raf appeared to be expressed at and has served as a valuable model for studies of cyst
relatively high levels in both the normal and abnormal pathogenesis and treatment. Although the chromosomal
cells lining cysts (Fig. 5 A and D). Figure 5A shows the location of the rat Cy gene is not syntenic with PKD 1
same cyst in Figure 3 C to I. The B-Raf reaction product or PKD 2 in humans, the renal features of the respective
could be eliminated in kidney sections by pre-incubation disorders are similar. The cysts develop focally in seg-
with immunizing peptide (Fig. 5B). B-Raf was weakly ments of renal tubule. In both species the development
expressed in/ kidneys, primarily in cortical distal and of cysts and progression to renal insufficiency are gender
collecting tubules (Fig. 5C). Raf-1 was not appreciably dependent, although the protection offered by female
expressed in / or Cy/ kidneys (Fig. 5 E and F). gender is greatest in the rat [27, 28]. Hypertension, a
Cellular localization of P-Raf-1 by immunohistochemis- feature of ADPKD in both rat and humans [29, 30],
try was not successful. develops long before the disease progresses to end-stage
Western blots showed that Rap-1 was more abundant function. Interestingly, rats homozygous for the Cy gene
in Cy/ than in / kidneys (1.27  0.08 fold, N  are born with relatively normal-appearing kidneys, but
7, P 0.01) (Fig. 6E). This small G protein was expressed within 3 weeks die of uremia due to massively expanded
at higher levels in epithelial cells lining cysts than in cystic kidneys (Fig. 1). It appears that in Cy/Cy animals
adjacent normal tubules (Fig. 6B) or tubules in normal the threshold for cystogenesis is drastically lowered and
renal cortex (Fig. 6A). cysts develop throughout the nephrons and collecting
One of the phosphorylated PKA regulatory subunits, ducts at break-neck speed. Similar behavior is observed
PKA RII
, was expressed in western blots at a higher in homozygous mice with targeted mutations in pkd-1
level in Cy/ than in / kidneys (2.20  0.39 fold, and pkd-2, except that the animals die in utero of vascular
N  4, P  0.039) (Fig. 6E). P-PKA catalytic subunits complications and enlarged cystic kidneys [31, 32]. The
were highly expressed in the majority of nuclei in cells human counterpart of the homozygous ADPKD rat and
lining cysts (Fig. 6D), in tubules in normal renal cortex mouse has not been described.
(Fig. 6C), and in medullary collecting duct cells (not Studies of the Han:SPRD Cy rat have revealed striking
shown). Unfortunately, the antibodies used for the im-
changes in the morphology of cells undergoing cystic
munohistochemistry of the PKA catalytic subunits were
transformation in the relatively few renal tubules des-not suitable for Western blots.
tined to become cysts. In the early stages of cyst forma-
tion, patches of abnormal cells that appear poorly differ-
DISCUSSION entiated and hyperplastic are found within otherwise
normal proximal renal tubules [9, 10]. The abnormalThe Han:SPRD rat model of ADPKD arose within a
colony of Sprague-Dawley rats in Hanover, Germany, cells express proliferating cell nuclear antigen (PCNA),
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Fig. 3. Phosphorylated extracellular-related
kinase (P-ERK) and ERK expression in 8-week-
old male/ and Cy/ kidneys. (A) ERK ex-
pression in /. Proximal tubules stained
weakly and distal tubules exhibited greater in-
tensity. (B) P-ERK was not expressed to a re-
markable degree in/. (C to I ) are from the
same region of a male Cy/ kidney and were
selected to show portions of normal tubules
undergoing cystic transformation. (C) P-ERK
expression in patches of epithelial cells (arrows)
lining cysts. No P-ERK expression observed
in noncystic structures. (D) Higher power view
of C showing P-ERK expression in patches of
epithelial cells lining cysts (arrows) and the
transition (*) between abnormal P-ERK ex-
pressing cells and adjacent cells of more nor-
mal phenotype. Tubule basement membrane
is thickened beneath P-ERK expressing cells
and the subjacent interstitium is widened and
infiltrated with mononuclear cells. (E) ERK
expression in same field as in (D). ERK was
diffusely expressed in cyst cells and adjacent
tubules and cells. (F) Hematoxylin and eosin
section of same field as (D) and (E). The cyto-
plasm of the P-ERK expressing cells in the
field stain faint pink, whereas other mural cells
stain dark pink. Curved line marks segment of
renal tubule that has undergone cystic transfor-
mation. (G) Higher power view of the abrupt
transition (*) between P-ERK expressing cells
and cells in which P-ERK is not expressed. (H)
Same view as (G) showing diffuse expression
of ERK. (I) Same view as (G) and (H) shows
hematoxylin and eosin staining of cells and ad-
jacent tissues. There is a sharp boundary be-
tween normal-appearing cells and hyperplas-
tic, P-ERK-expressing cells (*). This boundary
is reflected in the thickened basement mem-
brane beneath the P-ERK expressing cells and
the widened interstitium containing abnormal
numbers of mononuclear cells. Markers 
20 m.

Fig. 4. Expression of phosphorylated extracellular-regulated kinase (P-ERK) in Western blots and kidneys from male and female Cy/ and Cy/Cy.
Western blots from Cy/ littermates show that P-ERK expression was less in females than in males. Immunohistochemistry localized the expression
of P-ERK in male and female kidneys to cells lining the cysts. In males, especially, the tubule basement membrane beneath cells expressing high
levels of P-ERK was remarkably thickened and the subjacent interstitium was widened and contained mononuclear cells. Tubule basement
membrane and interstitial changes were less marked in the females. The asterisks mark a segment of a cyst wall in which P-ERK expression is
increased above that of most adjacent tubules. That segment is enlarged further in the adjacent panel. P-ERK expression was more widespread
in Cy/Cy kidneys involving mural cells lining cysts, as well as noncystic tubules and there were occasional mononuclear cells in the interstitium.
Tubule basement membrane changes were not as marked in the Cy/Cy as in the Cy/ animals. Markers  20 m.
Nagao et al: Extracellular signal-related kinase in rats with ADPKD 433
Fig. 6. Expression of Rap-1 and P-PKA in
/ and Cy/ kidneys. (A) Fig. 5 C and E are
from the same male /. Rap-1 was weakly
expressed in the tubules of /. (B) Fig. 5F
is from the same male Cy/. Rap-1 was ex-
pressed to a greater extent in cells lining cysts
than in adjacent normal tubules of Cy/ kid-
neys. (C ) Phosphorylated protein kinase A
(P-PKA) C
was expressed in renal cell nuclei
of/ kidneys. (D) P-PKA C
was expressed
in the nuclei of cystic epithelium. (E ) Western
blot of Rap-1, PKA RII
 and P-PKA RII

in two / and two Cy/ littermates. Rap-1
expression was greater in Cy/ than in /.
P-PKA RII
 expression was greater in Cy/
than in /.
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indicative of increased mitogenesis, and mRNA for type permitted quantitation by Western blot analysis, as well
as localization by immunohistochemistry. P-ERK levelsIV collagen [11]. There is an abrupt transition between
normal-appearing columnar cells with brush borders and were greatly elevated in the kidneys of cystic animals
relative to normal littermates of the same age, whereascytoplasm that stains pink with hematoxylin and eosin
and adjacent flattened cells with a high nucleus:cyto- levels of total ERK were not different (Fig. 2). This
result is consistent with the selective activation of ERKplasm ratio and light-staining cytoplasm (Figs. 3 and 4).
The tubule basement membrane immediately beneath within cystic kidneys. Immunohistochemistry localized
the source of the increased P-ERK levels to the muralthe normal-appearing cells is thin and the subjacent in-
terstitium is narrow and compact; by contrast, the tubule epithelial cells lining the cysts. Moreover, in cysts in
which the transition from normal to cystic phenotypebasement membrane underlying the cystic transformed
cells is thickened. The widened interstitium contains was in progress, the highest levels of P-ERK were found
in the abnormal-appearing cells (Figs. 3 and 4). P-ERKmononuclear cells (Figs. 3 to 6), identified in a recent
study as macrophages [12]. levels were evinced to a much greater extent in the ap-
parently transformed cells than in the morphologicallyIt appears in this rodent model that cysts may arise as
focal epithelial growths within widely scattered tubules. normal adjacent cells within the cysts, or in adjacent
noncystic proximal and distal tubules. This raises theThese patches of proliferating epithelium eventually lead
to ballooning of the tubule wall and to the formation of interesting possibility that cells with this abnormal mor-
phologic phenotype may be sensitive to stimulation bya saccular dilatation recognized as a cyst. Were this pro-
cess to proceed for several years, as it does in humans, agonists that activate the receptor tyrosine kinase/MAP
kinase pathway.more than likely the cysts would eventually separate
from the parent tubule and expand as isolated sacs owing In the current study we found that the levels of P-Raf-1
and Raf-1 were slightly, but significantly, increased into fluid transported into the lumen by transepithelial
secretion [33, 34]. the kidneys of Cy/ animals, indicating that this kinase
may be up-regulated (Fig. 2C). Examination of the cystsClearly, the abnormal proliferation of tubule epithelial
cells lies at the heart of cyst formation and expansion in did not reveal a source of the increase in P-Raf-1 expres-
sion determined by Western blot analysis as the Raf-1ADPKD [19, 35–38]. Studies in cultured cyst epithelial
cells removed from the discarded kidneys of patients expression in the mural cells lining cysts relative to adja-
cent normal tubules was not increased (Fig. 5F). B-Rafwith ADPKD have implicated cAMP as an important mi-
togen that drives abnormal rates of proliferation [16, 17], abundance was increased in Cy/ kidneys as determined
by both Western blot analysis (Fig. 2B) and this seemedas well as stimulating the transepithelial secretion of fluid
[33, 34]. Moreover, it appears that the mitogenic effect to be accounted for by an increase in the expression of
B-Raf in the mural epithelial cells of cysts (Fig. 5 Aof cAMP is a cellular phenotypic marker of abnormal
function. cAMP stimulates proliferation of human cyst and D). These findings suggest that B-Raf abundance is
up-regulated in cyst epithelium, although the extent toepithelial cells in culture together with the increased
phosphorylation of MAP kinase (ERK). Inhibition of which this kinase may have been activated could not be
determined since a suitable antibody to the phorphory-MAPKK (MEK) with a highly specific inhibitor blocked
the mitogenic response to cAMP of these cells as well lated form is not available.
Studies of cultured ADPKD cyst cells have implicatedas the activation of ERK. By contrast, cAMP does not
stimulate proliferation or ERK activation in cells derived an unusual mechanism through which cAMP may medi-
ate a mitogenic action in cyst epithelial cells. Epidermalfrom normal human renal cortex [16].
A major objective of the current study was to deter- growth factor (EGF) was found to activate ERK in cul-
tured ADPKD cyst cells [16]. Moreover, cAMP and EGFmine if the MAP kinase pathway was activated in an
animal model of ADPKD, and more specifically if the had complementary and synergistic effects on cell prolif-
eration and ERK activation in contrast to an anticom-activated kinase was expressed within the abnormal cells
that comprise renal cysts. In this, in contrast to an earlier plementary action of these agents in cells cultured from
normal human kidney cortex. In preliminary studies, Ya-study, we used antibodies to phosphorylated forms of
ERK to assess the activity of this kinase in situ as this maguchi et al (unpublished observations, 2002) have

Fig. 5. Expression of B-Raf and Raf-1 in 8-week-old-male / and Cy/. (A) B-Raf expression in same region shown in Fig. 3 D to I. B-Raf
was diffusely expressed in the mural cells of cysts, including both phosphorylated extracellular-regulated kinase (P-ERK) expressing and P-ERK
nonexpressing cells (see Fig. 3D). (B) Lack of B-Raf expression after preincubation with immunizing peptide. (C ) B-Raf expression in cortex of
/ animal. Faint B-Raf expression in cells of distal and collecting tubules. (D) Significant B-Raf expression in cysts of Cy/ kidney. Levels in
the cells appear to be greater than in adjacent normal tubules. (E ) Raf-1 expression in cortex of / animal. No segments with preferential
expression were detected. (F ) Raf-1 expression in Cy/. Levels were not increased in cyst epithelium. Marker  20 m.
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Fig. 7. Schematic model of adenylyl cyclase
and tyrosine receptor kinase pathways in au-
tosomal-dominant polycystic kidney disease
(ADPKD) cyst epithelial cells. In renal cyst
cells, extracellular-regulated kinase (ERK)
is activated by two convergent pathways.
Growth factors, for example, epidermal
growth factor (EGF), may bind to receptor
tyrosine kinase and activate the classical
pathway to extracellular-regulated kinase
(ERK). On the other hand, hormones, for ex-
ample, vasopressin, that elevate cyclic ade-
nosine monophosphate (cAMP) levels may
activate ERK through the intermediacy of
protein kinase A (PKA), Rap-1 and B-Raf.
cAMP also stimulates fluid secretion into
the cysts by promoting chloride transport
through cystic fibrosis conductance regula-
tor (CFTR). In this way the receptor tyrosine
kinase and adenylyl cyclase pathways to
ERK have an additive effect to accelerate
the rate of cellular proliferation and the pro-
gressive enlargement of renal cysts.
found that cAMP activates B-Raf, a serine threonine than in / (Fig. 6E). Taken together, these results pro-
vide indirect evidence that PKA is activated by cAMPkinase that activates MEK [39, 40], and confirmed that
in cystic kidneys of Han:SPRD Cy/ rats.EGF increased the levels of P-ERK in cultured ADPKD
Rap-1 is a small G protein that activates B-Raf uponcyst cells. Although cAMP activated B-Raf and EGF
stimulation by P-PKA [40, 42]. Rap-1 levels were greaterdid not, the adenylyl cyclase agonists had an additive
in Cy/ than in / kidneys (Fig. 6E) and the proteineffect on the expression of P-ERK. These findings indi-
was expressed at a greater level in the cysts than incate that adenylyl cyclase and receptor tyrosine kinase
noncystic tubules (Fig. 6 A and B). Thus, the cyst cellssignaling may operate in ADPKD cyst epithelial cells
harbor proteins that may enable cAMP to activate ERKthrough parallel pathways that converge in the comple-
through the intermediacy of B-Raf.mentary activation of ERK. While the current study does
B-Raf is distributed in relatively few organs and itsnot prove that B-Raf is activated in Han:SPRD kidneys,
activation is highly cell specific. In neuronal cells, forthe modest increase in the abundance of B-Raf is consis-
example, B-Raf is abundant and activated by Rap-1tent with the view that this component of the MAP
[40, 42]. Thus, elevated levels of cyclic AMP stimulatekinase pathway may be up-regulated and perhaps acti-
ERK through the successive activation of Rap-1, B-Rafvated by cAMP.
and MEK. By contrast, B-Raf is not activated by cAMPFurther evidence in support of a role for cAMP in the
in astrocytic cells; rather the cyclic nucleotide binds toCy/ rat was sought by determining the expression of ac-
Raf-1 leading to a blockade of the receptor tyrosine
tivated subunits of PKA in cyst epithelial cells (Fig. 6D). kinase cascade at MEK. PKA binds to B-Raf at two sites
The PKA holoenzyme is a heterotetramer composed of [43]. One of these sites leads to the activation of B-Raf
two N-terminally dimerized regulatory subunits com- by PKA and Rap-1 whereas binding to the other site
bined with two catalytic subunits, which are ubiquitously blocks this stimulation. Binding of PKA to the inhibitory
expressed in rodents [41]. When PKA is activated by site appears to be controlled by 14-3-3, a ubiquitous
cAMP subunits of the kinase localize within the nucleus. protein within cells. It is postulated that 14-3-3 binds to
In the current study, PKA C
 was detected in the nuclei the inhibitory site, shielding it from the inhibitory action
of renal epithelial cells in both normal and cystic animals, of PKA leaving the stimulatory site unopposed and re-
consistent with activation of PKA by cAMP (Fig. 6 C sponsive to activation by Rap-1 and activated PKA. In
and D). Western blot analysis of the catalytic subunit the last analysis the capacity of cAMP to activate ERK
was not successful. On the other hand, expression of may depend upon the relative abundances of B-Raf and
the phosphorylated regulatory subunit appeared to be 14-3-3 as renal tubule cells are transformed from a nor-
mal to an abnormal phenotype by polycystin mutations.increased in Western blots to a greater level in Cy/
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13. Grantham JJ: Polycystic kidney disease: from the bedside to theFigure 7 is a hypothetical scheme based on the current
gene and back. Curr Opin Nephrol Hypertens 10:533–542, 2001
work together with published information. cAMP is fre- 14. Grantham J, Cowley BJ, Torres VE: Progression of autosomal
dominant polycystic kidney disease (ADPKD) to renal failure, inquently elevated in renal cells owing to the actions of
The Kidney: Physiology and Pathophysiology (vol 2), edited byvasopressin, parathyroid hormone, prostaglandins, se-
Seldin D, Giebisch G, Philadelphia, Lippincott Williams & Wil-
cretin, and vasoactive intestinal peptide; thus, this second kins, 2000, pp 2513–2536
15. Grantham JJ, Calvet JP: Polycystic kidney disease: In danger ofmessenger has an important role in determining the ex-
being X-rated? Proc Natl Acad Sci USA 98:790–792, 2001tent to which the MAP kinase pathway may be activated
16. Yamaguchi T, Pelling JC, Ramaswamy NT, et al: cAMP stimu-
by extracellular agonists. Normally, cAMP is not mito- lates the in vitro proliferation of renal cyst epithelial cells by activat-
ing the extracellular signal-regulated kinase pathway. Kidney Intgenic and may serve to dampen mitogenic signals medi-
57:1460–1471, 2000ated through the receptor tyrosine kinase/MAP kinase
17. Hanaoka K, Guggino WB: cAMP regulates cell proliferation and
cascade. On the other hand, in cyst epithelial cells, cAMP cyst formation in autosomal polycystic kidney disease cells. J Am
Soc Nephrol 11:1179–1187, 2000is mitogenic and its action complements that of receptor
18. Matousovic K, Tsuboi Y, Walker H, et al: Inhibitors of cyclic nu-tyrosine kinase activation of the MAP kinase pathway.
cleotide phosphodiesterase isozymes block renal tubular cell prolif-
Thus, cyst cells may be unusually sensitive to mitogenic eration induced by folic acid. J Lab Clin Med 130:487–495, 1997
19. Grantham JJ: Renal cell proliferation and the two faces of cyclicstimulation by normal levels of circulating hormones and
adenosine monophosphate. J Lab Clin Med 130:459–460, 1997autocoids that increase the production of cAMP. 20. Cowley BD, Jr, Grantham JJ, Muessel MJ, et al: Modification of
disease progression in rats with inherited polycystic kidney disease.
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